FGF19 and hepatocellular carcinoma: In HCC, FGF19 binds to FGFR4 and forms a complex with FGF receptor substrate 2 and growth factor receptor-bound protein 2, leading to the activation of the Ras-Raf-ERK1/2 MAPK and PI3K-Akt pathways 45.